Skin biopsies from CTCL patients reveal a significant increase in the number of M2 macrophages expressing markers such as CD163 [23], CD63 [24], or CD68 [25]. Here, CD68 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.